SCHEMBL25920200

SCHEMBL25920200

CNC1CCC2(CC1)CCN(C(=O)c1ccc(Cl)c(N3CCC(=O)NC3=O)c1)CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.38
▸ GABRD O14764 3/20 0.36
▸ GABRA1 P14867 3/20 0.36
▸ GABRB1 P18505 3/20 0.36
▸ GABRA5 P31644 3/20 0.36
▸ GABRA3 P34903 3/20 0.36
▸ GABRA2 P47869 3/20 0.36
▸ GABRB2 P47870 3/20 0.36
▸ GABRA4 P48169 3/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CRBN Q96SW2 2/20 0.36
▸ DDB1 Q16531 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ENPP2 Q13822 1/20 0.35
▸ ATXN2 Q99700 1/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35
▸ IP6K1 Q92551 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25920235 0.90 KMT2A (0.39) MGLLGABRDGABRA1GABRB1GABRA5
SCHEMBL25920183 0.87 L3MBTL3 (0.43) MGLLGABRDGABRA1GABRB1GABRA5
SCHEMBL25920215 0.86 MAPK1 (0.48) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL28978062 0.86 MGLL (0.39) MGLLGABRDGABRA1GABRB1GABRA5
SCHEMBL30014467 0.85 FFAR4 (0.38) KMT2AFFAR4TNKSPARP1
SCHEMBL27123389 0.85 FFAR4 (0.38) KMT2AFFAR4TNKSPARP1
SCHEMBL30014819 0.85 HPGD (0.43) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL25596266 0.84 GABRD (0.51) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL30014379 0.84 GABRD (0.51) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL29893498 0.84 FFAR4 (0.45) MGLLKMT2AFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234936-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234936-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF IRAK4, IRAK2, IRAK1 MGLL 2676/4885GABRD 3732/4885GABRA1 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback